Back to Patient Profile

Patient Medical Report

Complete patient history, investigations, treatment and specialist opinions
Generated: 2026-09-25 06:08 Patient Record: 12
Full Name
خلود عيسى الحمزة
Identification Number
9682012695
Age
57
Gender
Female
Telephone Number
000008
Record Created
2026-08-03 09:59
Last Updated
-

History of Present Illness (HPI)

57Y F P9 all by NVD PMH: N PSH: Open chole 2020 Open tubal ligation 2007 NKDA 84KG NON SMOKER GIST with Omental Caking

Medical Conditions

0 record(s)
No medical conditions were recorded.

Family Medical History

0 record(s)
No family medical history was recorded.

Social History

No social history was recorded.

Surgeries

0 record(s)
No surgery records were recorded.

Chemotherapy

1 record(s)
Imatinib
2026-07-23 - Ongoing
Treatment Plan
FOR NEOADJUVANT IMATINIB 400mg *1

Radiology Records

7 record(s)
MRI - PELVIS MRI WITH IV CONTRAST
2026-07-27
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
There are heterogeneously enhancing and diffusion restrictive soft tissue intensity lesions seen at the site of both ovaries, enclose contact with the uterine wall, along with enhancing and diffusion restrictive diffuse soft tissue thickening involving the momentum with multiple peritoneal soft tissue deposits The urinary bladder is outlined smoothly. The rectum appears normal.
Impression
Appearances are mostly consistent with ovarian tumors with diffuse omental metastasis.
Notes
-
MRI - MRI ABDOMEN (Liver, kidney, pancreas) (MRCP)
2026-07-15
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
-
Impression
About 12mm well-defined hyperintense on T2 weighted images lesion seen in the segment VII of the liver which showed early enhancement on arterial phase and became isodense on the venous and delayed images without restriction on the DWI/ADC map suggesting flash filling hasmangiom. In addition, there is about 7mm hyperintense on T2 weighted images segment V lesion which could bot be assessed probably on postcontrast image due to artifact that likely representing haemangioma, however, correlation with U/S is advised. Right small perihepatic enhancing area which likely representing peritoneal deposit. Diffuse oedematous enhancing thickened omentum suggesting omental caking with multiple enhancing nodules.
Notes
-
Ultrasound - U/S guided Bx
2026-07-14
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
-
Impression
No ovarian mass detected by ultrasound scan to be targeted by ultrasound guided biopsy.
Notes
-
Endoscopy - UPPER ENDOSCOPY
2026-06-29
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
-
Impression
Stomach: Pan gastropathy
Notes
-
Endoscopy - Colonoscopy
2026-06-29
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
-
Impression
Caecum: 2 superficial tiny apthus ulcers. Bx taken
Notes
-
CT Scan - PAN CT
2026-06-25
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
-
Impression
An enhancing peri-heptic lesion with adjacent low attenuation area within the likely representing omental deposit with possible liver invasion. Otherwise, no CT evidence of focal liver lesion. Diffuse enhancing omental lesions, suggesting omental caking. The pancreas, both adrenal glands and both kidneys are grossly unremarkable. No significant intra-abdominal free fluid. 6 x 7 cm isodense to the omental caking mass seen in the right side of the pelvis with small central gas locules, this mass could represent the patient’s known ovarian tumour with possible invasion of the adjacent bowel, proper evaluation by pelvic MRI is advised.
Notes
-
Histopathology - US GUIDED OMENTAL BX
2026-06-09
Status
Completed
Attached Files
0
Facility
-
Radiologist
-
Clinical Indication
-
Findings
-
Impression
OMENTAL BX: Gastrointestinal stromal tumor C-Kit, Dog1, SMA, Cd34: positive Desmin, S100: negative
Notes
-

Specialist Opinions

2 record(s)
Radiation Therapy
2026-08-03
Specialist Name
-
Opinion Note
Can be role for neoadjuvant radiotherapy If no response imatinib after 3 months
Recommendation
-
Medical Oncology
2026-08-03
Specialist Name
-
Opinion Note
Imatinib 400mg
Recommendation
Imatinib 400mg ×1 for 3 months The reevaluation for clresectability

Laboratory Tests

2 record(s)
Date Test Category Result Reference Range Status Notes
2026-06-07 AFP Tumor Markers 1.45 Ng/ml Up to 10 (smoker) up to 5 (non-smoker) Normal -
2026-06-07 CA-125 Tumor Markers 205.1 U/ml 0-35 High -